[just Scottie]

Now in the expert market
What a complete joke

[Doubledown75]

I'm buying AFFU now Rich and chart are buying 
I'd say we got a good chance to make some money back. 
Sonendo and that beaver chick are rat poison.

[Chartmaster]

Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Sonendo, Inc. (“Sonendo” or the “Company”) (OTC Pink: SONX), a leading dental technology company and developer of the GentleWave® System, today reported select financial results for the first quarter ended March 31, 2025 and issued short and long-term financial guidance.

Recent Highlights

Generated $7.4 million of total revenue for the first quarter of 2025, representing 5% growth compared to the prior year period;
Drove a substantial increase in gross margin to 44% for the first quarter of 2025, up 1600 basis points compared to the 28% gross margin for the prior year period;
Reported a 48% year-over-year improvement in Adjusted EBITDA loss to $3.9 million for the first quarter of 2025;
Significantly reduced free cash flow burn to $4.5 million, a 58% reduction compared to the prior year period;
Recently completed a $5.0 million private placement of its common stock, which included new and existing investors;
Amended its credit facility to defer principal amortization payments until at least September 2025, and potentially until March 31, 2026.

“We are pleased that our lender and the new and existing investors who participated in the private placement have recognized the meaningful success we have achieved in restructuring the business and increasing revenue while significantly reducing operating expenses and free cash flow burn, as demonstrated in our first quarter 2025 financial and operational results,” said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. “We have significantly improved the liquidity profile of the Company, and we expect to deliver additional gross margin expansion and further reductions in operating losses and free cash flow burn in 2025. We remain steadfastly committed to operational excellence and to position Sonendo for robust, long-term and profitable growth.”

As of March 31, 2025, the Company’s cash, cash equivalents and short-term investments totaled $7.2 million, which does not include the $4.7 million in estimated net proceeds the Company received in the private placement, and there was $14.2 million of principal outstanding under its credit facility.

Financial Guidance

The Company is providing the following short and long-term financial guidance, which reflects management’s latest expectations.




2025


Mid-Term (2027)


Long-Term (2029)

Revenue


$31-$32 million





9% CAGR (2024-2029)

GAAP Gross Margin


44-46%


57-59%


65%+

Adjusted EBITDA(1)


$(11)-$(14) million


(8)-(10)% of revenue


+8-10% of revenue(2)

Free Cash Flow(1)


$(12)-$(15) million





Positive


(1)


See additional information included in the Company’s Form 8-K filed with the SEC on November 12, 2024 for additional information about the Company’s use of these non-GAAP financial measures.


(2)


The Company expects to generate positive adjusted EBITDA starting in FY 2028.

About Sonendo

Sonendo is a commercial-stage medical technology Company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices.

For more information about Sonendo and the GentleWave System, please visit www.sonendo.com. To find a GentleWave doctor in your area, please visit www.gentlewave.com.

Forward Looking Statements

This news release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the Company’s expectations regarding short- and long-term financial performance, including (among other things) GAAP gross margin, adjusted EBITDA and free cash flow; the Company’s expectations to deliver additional gross margin expansion and further reduce operating losses and free cash flow burn in 2025; and the Company’s ability to achieve robust, long-term and profitable growth. You are cautioned that such statements are not guarantees of future performance and that our actual results may differ materially from those set forth in the forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions; speak only as of the date they are made; and, as a result, are subject to risks and uncertainties that may change at any time. Factors that could cause the Company’s actual results to differ materially from these forward-looking statements are described in detail in the “Risk Factors” section of the Company’s Annual Report on Form 10-K that was filed with the Securities and Exchange Commission on March 26, 2025. Such filings are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as may be required under applicable securities laws. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

https://cts.businesswire.com/ct/CT?id=bwnews&sty=20250604534828r1&sid=acqr8&distro=nx&lang=en

View source version on businesswire.com: https://www.businesswire.com/news/home/20250604534828/en/

Investor Contact:
[e-mail]

Source: Sonendo
https://www.otcmarkets.com/stock/SONX/news/Sonendo-Inc-Reports-First-Quarter-2025-Financial-Results-and-Issues-Financial-Guidance?id=481822
© Copyright Business Wire 2025

[RichieBoy]

Hmmm Bjarne appears to have lost his way with a second R/S. Here's AI's opinion.

"Sonendo just did a Reverse Split. Is this good for liquidity or is this bad for shareholders please?"

A reverse split like Sonendo’s recent 1-for-200 move generally has mixed effects for shareholders and liquidity.

For liquidity:

In the short term, a reverse split can sometimes increase liquidity by raising the share price, making the stock more attractive to institutional investors who avoid penny stocks.

However, over the medium and long term, reverse splits often reduce liquidity because there are fewer shares available to trade, which can increase bid-ask spreads and transaction costs.

For shareholders:

Reverse splits are often viewed negatively by the market, as they can signal financial distress or an attempt to avoid delisting due to a low share price.

While the higher price per share may improve the company’s image, the total value of each shareholder’s investment remains the same, but with fewer shares. This can harm investor confidence and may result in some shareholders selling their positions.

In summary:

Short-term liquidity may improve, but longer-term liquidity and investor sentiment often suffer after a reverse split.

The move is generally seen as a negative signal for shareholders unless it is part of a broader, successful turnaround strategy.

[Doubledown75]

wtf lol

[just Scottie]

After the split ss was 428,514
Now it’s 4,148,514

[just Scottie]

Are they dumping shares now?

[just Scottie]

Yeah it’s all a mystery for now. They supposedly did a RS to prevent from going pink but they ended up on the pink sheets anyway and filed a 15-12g form which releases them of sec reporting. 😳
Only good thing is the os structure which is tiny, but I’m sure an offering is in the future but hopefully it’s after the price has risen with some good news.
428,514 OS

[RichieBoy]

Bon chance! Mon ami

To evaluate whether a private placement financing is legitimate or predatory, investors should assess transparency, terms, and alignment of interests. Here’s how to distinguish between beneficial and harmful offerings:

Red Flags of Predatory Private Placements
Lack of Transparency

Missing or vague financial statements, undisclosed fees, or refusal to provide an audited balance sheet or income statement.

No clear explanation of how funds will be used or overly broad claims (e.g., "general corporate purposes").

Unrealistic Promises

Guaranteed returns, "risk-free" claims, or pressure to invest quickly without time for due diligence.

Overly complex structures (e.g., toxic convertible notes with aggressive conversion terms that dilute existing shareholders).

Regulatory Issues

Issuers or promoters with disciplinary histories (e.g., barred from securities industries).

Use of Regulation D exemptions without proper accreditation checks or misuse of exemptions to bypass investor protections.

Misaligned Incentives

Excessive upfront fees or compensation tied to fundraising success rather than long-term performance.

Aggressive sales tactics targeting financially vulnerable investors.

Positive Indicators of Legitimate Offerings
Comprehensive Documentation

A Private Placement Memorandum (PPM) detailing business operations, risks, financials, and use of proceeds.

Audited financial statements and verifiable track records of management.

Investor Protections

Clear alignment with accredited investor criteria (e.g., income or asset thresholds).

Reasonable valuation metrics and terms that avoid excessive dilution (e.g., fixed conversion prices for equity-linked securities).

Regulatory Compliance

Proper SEC filings (e.g., Form D) and adherence to exchange rules for public companies conducting private placements.

Transparent communication about risks, including market volatility and liquidity constraints.

Steps for Investor Due Diligence
Verify Credentials: Check the issuer’s regulatory history using tools like FINRA’s BrokerCheck or the BCSC’s InvestRight.org.

Scrutinize Financials: Demand audited statements and cross-reference claims with independent sources.

Understand Terms: Avoid deals with hidden fees, short repayment windows, or punitive conversion mechanisms.

Consult Advisors: Engage legal or financial experts to review the PPM and term sheets.

By prioritizing transparency, regulatory compliance, and investor alignment, stakeholders can mitigate risks in private placements

[RichieBoy]

If this is a PIPE to be on the safe side, frankly I'd be leery who this private investor is. It's also directors and officers within the company investing. Including new investors but there's a main new investor for this big a restructuring IMHO.

Brookline Capital Markets, as a division of Arcadia Securities LLC, provides financial instruments and services such as:

Pre-IPO financings

IPOs

Secondary offerings

PIPEs (Private Investments in Public Equity)

Trade facilitation for private equities

Capital markets and strategic advisory services

If SONX is collaborating with Brookline, it would typically be for these financial services and capital-raising MECHANISMS.

[RichieBoy]

Arcadia Securities LLC is a New York-based, full-service broker-dealer founded in 1998. The firm provides investment banking, capital markets, and financial advisory services to corporate clients, family offices, high net worth individuals, and institutions. Arcadia is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and is a member of the Financial Industry Regulatory Authority (FINRA). Its principal office is located at 1370 Avenue of the Americas, 29th Floor, New York, NY 10019.

The company offers services including investment banking, private placements, financial advisory, and securities transactions (both agency and principal). Thomas P. Kikis is the President and Managing Member. Arcadia Securities operates several branded divisions, such as Brookline Capital Markets and B. Dyson Capital Advisors.

[just Scottie]

Still here waiting getting ready to ave down lol. Hope all is well Rich

[RichieBoy]

Well there is always a silver lining Scottie
Let's hope the company can elevate prospects this time!

[RichieBoy]

Are you excited yet?
and we expect to deliver additional gross margin expansion and further reductions in operating losses and free cash flow burn in 2025.

[Chartmaster]

Sonendo, Inc. Announces $5.0 Million Private Placement

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Sonendo, Inc. (OTC PINK: SONX) (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today announced a private placement of common stock, resulting in gross proceeds of $5.0 million (the “Private Placement”). New and existing investors, including certain directors and officers of the Company, participated in the financing.

Sonendo intends to use the proceeds from the financing to expand commercial programs to drive revenue growth, continue executing ongoing business restructuring activities to further reduce operating expenses and accelerate the path to positive adjusted EBITDA and operating cash flow, to retain senior leadership and key employees and for working capital as well as other general corporate purposes.

The Company entered into securities purchase agreements with investors to sell an aggregate of 4,000,000 shares of the Company’s common stock, par value $0.001 at a purchase price per share of $1.25, which reflects an approximately 10% premium to the most recent closing price.

Brookline Capital Markets, a division of Arcadia Securities, LLC, served as the sole placement agent for the Private Placement.

The securities to be sold in the Private Placement have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or applicable state securities laws, and accordingly may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

Additionally, on March 31, 2025, Sonendo entered into Amendment No. 5 (the “Amendment No. 5”), and on April 25, 2025, Sonendo entered into Amendment No. 6 (the “Amendment No. 6”, together with Amendment No. 5, the “Amendments”) to its Amended and Restated Credit Agreement and Guaranty, dated as of August 23, 2021, by and among the Company, the subsidiary guarantor named therein, the lenders party thereto and Perceptive Credit Holdings III, LP, as amended (the “Credit Agreement”). The Amendments amended the Credit Agreement, to, among other things, (i) reduce the minimum gross proceed requirements for certain equity financings and capital-raising transactions condition and (ii) subject to the consummation of the transactions in clause (i) (A) waive amortization payments originally due on February 28, 2025 and March 31, 2025 and (B) defer amortization payments due during the period beginning on April 30, 2025 and ending immediately prior to March 31, 2026.

“We are pleased that our lender and these new and existing investors participating in the private placement have recognized the meaningful success we have achieved in restructuring the business and stabilizing revenue while significantly reducing operating expenses and free cash flow burn, as demonstrated in our 2024 financial and operational results,” said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. “We have significantly improved the liquidity profile of the Company via the private placement and the recent amendments to our credit facility, and we expect to deliver additional gross margin expansion and further reductions in operating losses and free cash flow burn in 2025. We remain steadfastly committed to operational excellence and to position Sonendo for robust, long-term and profitable growth.”

About Sonendo

Sonendo is a commercial-stage medical technology Company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo develops and manufactures the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. The clinical benefits of the GentleWave System when compared to conventional methods of root canal therapy include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices.

For more information about Sonendo and the GentleWave System, please visit www.sonendo.com. To find a GentleWave doctor in your area, please visit www.gentlewave.com.

Forward Looking Statements

This press release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, express or implied forward-looking statements relating to the Company’s anticipated business and financial performance on an on-going basis. You are cautioned that such statements are not guarantees of future performance and that our actual results may differ materially from those set forth in the forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions; speak only as of the date they are made; and, as a result, are subject to risks and uncertainties that may change at any time. Factors that could cause the Company’s actual results to differ materially from these forward-looking statements are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission, including the “Risk Factors” set forth in our Annual Report on Form 10-K. Such filings are available on our website or at www.sec.gov. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as may be required under applicable securities laws. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

https://cts.businesswire.com/ct/CT?id=bwnews&sty=20250501156462r1&sid=acqr8&distro=nx&lang=en

View source version on businesswire.com: https://www.businesswire.com/news/home/20250501156462/en/

Investor Contact:
[e-mail]

Source: Sonendo

© Copyright Business Wire 2025
https://www.otcmarkets.com/stock/SONX/news/Sonendo-Inc-Announces-50-Million-Private-Placement?id=475777

[just Scottie]

No telling what direction this goes

[Doubledown75]

Ya that split hurtI don't want to add here anymore.The company sold their souls to the devil.

[just Scottie]

We need a miracle

[Doubledown75]

We need doge sonendo;)

[just Scottie]

I agree

[Mjmurr13]

Highway robbery. F*ck the CEO and this company.

[Doubledown75]

Shady shit went on here 
Hope doge looks in SONX.
BASL went bankrupt and sold off to the Koreans, beaver gets our BOD.

[just Scottie]

Things are pointing to them going dark now on the Expert market imo
What a financial disaster holding this pos ol

[just Scottie]

Same! My average is $7.50 post split.
Not adding anymore now that they don’t have to report and went pink

[Mjmurr13]

I feel like such a moron for investing, and wish I would have never discovered the existence of this company. I feel bad for anyone that put money into them, no matter the amount. I know this will haunt and hold me back for years to come. I wish everyone the best.

[just Scottie]

They don’t have to report. They split to avoid pink sheets and are now a pink sheet WTF

FUCK RETAIL IS THIS CEO’S MO

https://fintel.io/doc/sec-sonendo-inc-1407973-1512g-2025-february-27-20146-8633?utm_source=twitter.com&utm_medium=referral&utm_campaign=filing

I guess we are fucked

15-12G" refers to a form filed with the Securities and Exchange Commission (SEC) called "Form 15-12G," which is used by a company to certify that it is terminating its registration of a class of securities under Section 12(g) of the Securities Exchange Act, essentially meaning they are "going dark" and no longer need to file regular reports with the SEC because they have a low number of shareholders and meet specific asset thresholds; it signifies the company is deregistering its securities and is no longer required to publicly disclose financial information

[Doubledown75]

What's going on today?

[just Scottie]

It’s thin, only 427,000 shares outstanding
I think most that wanted out sold for a tax loss.
It opened post split at $5 I think, it’s just working its way back.
They have reduced spending and working for a break even point. Even with that I believe he needs an acquisition or partnership to garner interest and support to think about getting back to the big board again.
At some point he will do an offering hopefully it’s after big news

[RichieBoy]

You guys are in far closer touch than I am

But something's created a gap up. Any theories, clues, assertions?

[just Scottie]

I’ll be holding till kingdom come unless they acquire, be acquired or merge with an entity larger to generate interest

[Mjmurr13]

Same 'Ole story here; the ones that believed in the company and BOD, and invested heavily in the company after the 5 hedge funds, will be the ones who will continue to lose. The amount they split speaks volumes on how much they care about their retail investors, and it will be nearly impossible for those retail investors, like myself, to recoup their investment prior to the split. It's sad too, because I actually had faith that this investment was going to be life changing, or at least a step in the right direction.

[RichieBoy]

Flabbergasted, was such a great company.
When all those 5 industrial funds showed up en masse that one day. I did a double take. The wolves were hungry. That's where I got my itchy feet. No fanfare, no public info, really got gun shy after that. Family office right, it will come back in it's own sweet time. Lord knows when, that's the only thing. All the best in 2025.You guys deserve a break here, just plain nasty.

[just Scottie]

Only good thing for an otc stock is the fact of only 426,000 outstanding shares
We just need some good news and a pump
Thin as hell

[just Scottie]

Yeah Bjarne fucked retail real good in 2024

[Doubledown75]

Ya think?? lol
We are trading at 0.0075 pre RS now, and we don't even go bankrupt. Biolase gave us Carolyn Beaver as BOD though. Don't think it was a present for the shareholder either;) 

[RichieBoy]

Hunch I'd best postpone that call to Bjarne

Are you guys taking it on the nose as well as the crotch? Sure looks like it. Any rate Merry Christmas you guys. Sad the company is floundering. Hopefully he has something GOOD up his sleeve for the new year. You sure deserve some fresh air here, one way traffic speaks volumes as to market sentiment. ALL the best in the New Year!

[Doubledown75]

I doubt pura needs then to do another RS.

[just Scottie]

https://www.gurufocus.com/news/2603975/pura-vida-investments-llc-acquires-new-holdings-in-sonendo-inc

[just Scottie]

Yup once again the spectacular Sonx

[Doubledown75]

So now we are SONX and not SONXD?

[just Scottie]

Sonendo President and CEO Bjarne Bergheim said the company was "disappointed" with the decision, but would continue to "evaluate financing options and other strategic alternatives" for itself.

5. In a 10-Q form filed with the Securities and Exchange Commission Nov. 7, Biolase said the winning bid came from MegaGen Implant Co., a South Korean-based dental implant company, while Sonendo's offer was named the backup bid.

6. Biolase said its sale to MegaGen is subject to definitive documentation between the two companies.

[just Scottie]

Going to be a lot of tax loss selling this month. I reluctantly have been adding to get my ave down

[RichieBoy]

2.06 👆 2.035 (8,140.00%)

Well it's not April 1st yet. Hmmm by my calendar at least anyways. Wouldn't this be commonly known as a trading anomaly when the stock has 81 Xed in a day under seemingly normal circumstances?

... I'm just new here 🍹🍸🥃🍻 Another round and keep them coming bartender (hic)

[Doubledown75]

Hell just take it to 0.0001
Sonendo wtf??

[RichieBoy]

Patents, intellectual property.

[Doubledown75]

I say buyout
How the biolase extended into sonendo baffles me and then wa laa beaver is on the BOD?? Why would a Korean company that makes implants but biolase?? Take out the competition?

[just Scottie]

It would be better than what we have going

[Doubledown75]

Maybe he will buy bitcoin for the company?;)

[just Scottie]

Yeah i don’t think he will make a big board comeback on just a technology to clean roots during a root canal procedure. He needs more to offer imo

[RichieBoy]

Strategically Bjarne's back to Square One
If not overextended, what a mess. He got mauled by some rogue CEO who clearly hadn't understood Intellectual Property rights. Now he has to rebuild hence the restructuring which was what made me take the loss in the first place. I suppose he could JV with Korea . But who wants to deal with different language, different currency, different culture, different time zones on a daily basis.

Either he gets acquired, or comes up with a new gizmo. That's why I wanted to talk with the guy, truly understand his realistic options.